All (n = 120) | Cognitively normal (CDR 0) (n = 48) | Cognitively impaired (CDR 0.5 or 1) (n = 72) | |
---|---|---|---|
Age, years | 70.4 (7.9) | 66.0 (7.4) | 73.3 (6.9)a |
Male sex, n (%) | 43 (35.83%) | 17 (35.42%) | 26 (36.11%) |
Education, years | 12.4 (2.6) | 13.2 (2.3) | 11.8 (2.7)a |
MMSE score, mean | 26.9 (3.1) | 28.5 (1.4) | 25.9 (3.5)a |
APOE ε4 carrier, n (%) | 37 (30.83%) | 11 (22.92%) | 26 (36.11%)a |
CSF parameters | |||
Aβ1–42, pg/ml | 847.4 (265.1) | 957.4 (194.0) | 774.0 (281.5)a |
tau, pg/ml | 371.3 (278.6) | 221.5 (82.9) | 471.1 (316.6)a |
p-tau181, pg/ml | 62.0 (35.2) | 45.9 (13.3) | 72.7 (40.9)a |
p-tau181/Aβ1–42 | 0.088 (0.082) | 0.049 (0.015) | 0.114 (0.097)a |
Albumin indexb | 6.1 (2.4) | 5.3 (1.9) | 6.6 (2.5)a |
Choline, μM | 2.7 (0.5) | 2.6 (0.4) | 2.8 (0.6)a |
Cystathionine, nM | 35.8 (17.0) | 34.4 (13.8) | 36.7 (18.9) |
Methionine, μM | 3.6 (0.8) | 3.3 (0.5) | 3.9 (0.9)a |
S-adenosylhomocysteine, nM | 15.1 (5.8) | 13.5 (4.3) | 16.1 (6.3)a |
S-adenosylmethionine, nM | 183.0 (42.0) | 188.2 (41.1) | 179.4 (42.5) |
Serine, μM | 27.1 (4.7) | 25.7 (4.1) | 28.0 (4.8)a |
Cysteine, μM | 1.2 (0.4) | 1.2 (0.4) | 1.3 (0.4) |
5-Methyltetrahydrofolate, nM | 45.1 (12.5) | 47.2 (10.9) | 43.8 (13.4) |
Plasma parameters | |||
Cystathionine, nM | 252.3 (232.4) | 267.5 (290.0) | 242.1 (185.9) |
Glycine, μM | 234.5 (60.6) | 235.9 (59.7) | 233.6 (61.5) |
Methionine, μM | 19.7 (3.6) | 19.4 (2.9) | 19.9 (4.1) |
S-adenosylhomocysteine, nM | 20.9 (9.1) | 18.3 (6.3) | 22.7 (10.2)a |
S-adenosylmethionine, nM | 71.9 (20.7) | 67.6 (17.7) | 74.7 (22.2) |
Serine, μM | 115.3 (19.9) | 111.5 (16.9) | 117.9 (21.3) |
Cysteine, μM | 158.3 (20.3) | 150.7 (18.4) | 163.3 (20.1)a |
Homocysteine, μM | 5.6 (1.6) | 5.3 (1.5) | 5.8 (1.7) |